Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol dose study for colonoscopy sedation across BMI groups
ChiCTR2400079345Phase 4Recruiting
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Jan 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in None (3 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoints: Ciprofol induced dose, First addition interval and total number of additions and 1 more. Started Jan 2024; status: recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2400079345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079345.